F-group (family)
207.1.1.145 LRR_1, LRR_5, LRR_8, LRR_12
Ligands and drugs
70
Member domains
68
with ligand contacts (≤ 4 Å)
97.1% of members
48
with DrugDomain annotations
68.6% of members
45
with a DrugBank compound
64.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 207.1.1.145 belongs to X-group 207 Single-stranded right-handed beta-helix, which binds 6.1 ligand superclasses per 20 proteins, narrower than 73% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 44 |
| DB02857 | GMP | Guanosine | 3 |
| DB00724 | 6T0 | Imiquimod | 2 |
| DB06530 | RX8 | Resiquimod | 2 |
| DB12687 | 9JR | Vesatolimod | 2 |
| DB17589 | SDL | Loxoribine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 61 |
| IDQ | 1-[[4-(aminomethyl)phenyl]methyl]-2-butyl-imidazo[4,5-c]quinolin-4-amine | 10 |
| 9K9 | 2-amino-9-[(2S,3aR,4R,6R,6aR)-2-hydroxy-6-(hydroxymethyl)-2-oxotetrahydro-2H-2lambda~5~-furo[3,4-d][1,3,2]dioxaphosphol-4-yl]-3,9-dihydro-6H-purin-6-one | 4 |
| GMP | GUANOSINE | 4 |
| 23G | GUANOSINE-5'-PHOSPHATE-2',3'-CYCLIC PHOSPHATE | 2 |
| 6T0 | 1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine | 2 |
| 9JR | 4-azanyl-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one | 2 |
| 9K3 | 1-{4-amino-2-[(ethylamino)methyl]-1H-imidazo[4,5-c]quinolin-1-yl}-2-methylpropan-2-ol | 2 |
| A1BLT | (3S)-3-[(2-amino-5-{[2-methoxy-5-({[(3S)-oxolan-3-yl]amino}methyl)phenyl]methyl}-5H-pyrimido[5,4-b]indol-4-yl)amino]hexan-1-ol | 2 |
| ACK | 2',3'- cyclic AMP | 2 |
| C09 | 2-(ethoxymethyl)-1H-imidazo[4,5-c]quinolin-4-amine | 2 |
| EWL | 6-azanyl-2-butoxy-9-(phenylmethyl)-7H-purin-8-one | 2 |
| EWU | 6-azanyl-2-(2-methoxyethoxy)-9-(phenylmethyl)-7H-purin-8-one | 2 |
| EWX | 6-azanyl-2-(2-methoxyethoxy)-9-(pyridin-3-ylmethyl)-7H-purin-8-one | 2 |
| EX0 | 2-ethoxy-8-(5-fluoranylpyridin-3-yl)-9-[[4-[[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]methyl]purin-6-amine | 2 |
| EX3 | 2-ethoxy-8-(5-fluoranylpyridin-3-yl)-6-methyl-9-[[4-[[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]methyl]purine | 2 |
| GJX | (1S,3R)-5-[4-(8-nitroquinolin-5-yl)piperazin-1-yl]carbonyladamantan-2-one | 2 |
| JRI | (2R,6R)-4-(8-cyanoquinolin-5-yl)-N-[(3S,4R)-4-fluoranylpyrrolidin-3-yl]-6-methyl-morpholine-2-carboxamide | 2 |
| L07 | 2-propyl[1,3]thiazolo[4,5-c]quinolin-4-amine | 2 |
| QCX | (3S)-3-({5-amino-1-[(2-methoxy-4-{[(oxan-4-yl)amino]methyl}phenyl)methyl]-1H-pyrazolo[4,3-d]pyrimidin-7-yl}amino)hexan-1-ol | 2 |